Call Options

1 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2018

Mar 28, 2019

BUY
$60.54 - $79.0 $72,648 - $94,800
1,200 New
1,200 $15,000

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $110B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Kg&L Capital Management,Llc Portfolio

Follow Kg&L Capital Management,Llc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kg&L Capital Management,Llc, based on Form 13F filings with the SEC.

News

Stay updated on Kg&L Capital Management,Llc with notifications on news.